Systemic sclerosis & Raynaud's

Long-term organ damage accrual and late mortality in systemic sclerosis

Clin Exp RheumatolPublished Retrospective cohort study

Authors' conclusion

Factors associated with damage accrual in SSc patients with long-term follow-up were identified. Higher SCTC-DI and higher SCTC-DI annual rise were associated with late mortality in SSc.

Study context

Population
Patients with systemic sclerosis (SSc) with a baseline visit at diagnosis and at least 10 years of follow-up after diagnosis
Participants
253 patients
Outcome
Long-term evolution of organ damage accrual measured by SCTC-DI
Follow-up
10 years after diagnosis
Methodological detailssingle-centre, multivariable analyses
  • Single-centre
  • Multivariable analyses

Main finding

As reported in the abstract

Organ damage accrual (SCTC-DI)

Moderate or severe damage at 10 years

34%

Observational data: associations, not effects.

Further findings

Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI) score and annual rise by subset and ACA status · During follow-up

Higher SCTC-DI score and higher annual rise in dcSSc than in lcSSc
Higher SCTC-DI score and higher annual rise in ACA-negative than in ACA+

Factors associated with moderate or severe damage

dcSSc, lack of ACA and SCTC-DI scores at previous timepoints independently associated with moderate or severe damage
  • Multivariable analyses

SCTC-DI and late mortality (death >10 years after diagnosis)

SCTC-DI significantly higher at baseline and at every timepoint, with a higher annual rise, in late mortality vs surviving patients

Original publication

Long-term organ damage accrual and late mortality in systemic sclerosis. Clin Exp Rheumatol. Published 15 June 2023. doi:10.55563/clinexprheumatol/2xiitt

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.